{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:59:11Z","timestamp":1769763551385,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ijcha.2024.101473","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T19:49:07Z","timestamp":1721764147000},"page":"101473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cardiac sarcoidosis treated with nonsteroidal immunosuppressive therapy"],"prefix":"10.1016","volume":"53","author":[{"given":"Kenichiro","family":"Suwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9630-951X","authenticated-orcid":false,"given":"Yoshihisa","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Nabeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsunori","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2024.101473_b0005","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ijcha.2024.101473_b0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.resinv.2022.02.001","article-title":"Basal interventricular septum thinning and long-term left ventricular function in patients with sarcoidosis","volume":"60","author":"Tanizawa","year":"2022","journal-title":"Respir Investig"},{"key":"10.1016\/j.ijcha.2024.101473_b0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11886-018-1065-9","article-title":"Echocardiography in Sarcoidosis","volume":"20","author":"Kurmann","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.ijcha.2024.101473_b0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/hrt.57.3.256","article-title":"Sarcoidosis: a pattern of clinical and morphological presentation","volume":"57","author":"Valantine","year":"1987","journal-title":"Br Heart J"},{"key":"10.1016\/j.ijcha.2024.101473_b0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjcard.2019.05.020","article-title":"Comparison of Clinical and Morphologic Findings in Patients With Cardiac Sarcoidosis Severe Enough to Warrant Heart Transplantation in Those With -vs- Those Without Non-Caseating Granulomas in the Explanted Heart (Burnt-Out Sarcoid)","volume":"124","author":"Fathima","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcha.2024.101473_b0030","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/heartjnl-2022-321379","article-title":"Cardiac sarcoidosis","volume":"109","author":"Sohn","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.ijcha.2024.101473_b0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.ijcha.2024.101473_b0040","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.ijcha.2024.101473_b0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac Sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcha.2024.101473_b0050","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis - Digest Version -","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.ijcha.2024.101473_b0055","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ijcha.2024.101473_b0060","first-page":"217","article-title":"Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: a single center real-world study","volume":"36","author":"Fang","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ijcha.2024.101473_b0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/thx.54.8.742","article-title":"A clinical approach to the use of methotrexate for sarcoidosis","volume":"54","author":"Baughman","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.ijcha.2024.101473_b0070","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/eurheartj\/ehac323","article-title":"Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry","volume":"43","author":"Nabeta","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcha.2024.101473_b0075","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ijcha.2024.101473_b0080","article-title":"Non-steroidal treatment of cardiac sarcoidosis: a systematic review","volume":"34","author":"Gallegos","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.ijcha.2024.101473_b0085","doi-asserted-by":"crossref","first-page":"e010952","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ijcha.2024.101473_b0090","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s12350-022-03171-6","article-title":"Prednisone vs methotrexate in treatment naive cardiac sarcoidosis","volume":"30","author":"Vis","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.ijcha.2024.101473_b0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2169\/internalmedicine.53.0794","article-title":"Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.ijcha.2024.101473_b0100","article-title":"Effectiveness of methotrexate as a second-line treatment for cardiac sarcoidosis assessed via (18)F-FDG PET: a case report","volume":"6","author":"Dotare","year":"2022","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.ijcha.2024.101473_b0105","article-title":"Prospective analysis of immunosuppressive therapy in cardiac sarcoidosis with fluorodeoxyglucose myocardial accumulation: PRESTIGE study","author":"Morimoto","year":"2023","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724001398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724001398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T21:50:29Z","timestamp":1733608229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906724001398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":21,"alternative-id":["S2352906724001398"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101473","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac sarcoidosis treated with nonsteroidal immunosuppressive therapy","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101473"}}